Long-term effects of finasteride on prostate tissue composition.
about
Finasteride for benign prostatic hyperplasia5alpha-reductase: history and clinical importanceClinical value of prostate segmentation and volume determination on MRI in benign prostatic hyperplasia.Molecular and cellular prostate biology: origin of prostate-specific antigen expression and implications for benign prostatic hyperplasia.Chemoprevention of prostate cancer with finasteride.5α-Reductase Isozymes in the ProstateFinasteride and doxazosin alone or in combination for the treatment of benign prostatic hyperplasia.Is transforming growth factor-β signaling activated in human hypertrophied prostate treated by 5-alpha reductase inhibitor?A systematic review of the effects and mechanisms of preoperative 5α-reductase inhibitors on intraoperative haemorrhage during surgery for benign prostatic hyperplasia.Benign prostate hyperplasia and stem cells: a new therapeutic opportunity.An introduction to acinar pressures in BPH and prostate cancer.A synopsis of drugs currently in preclinical and early clinical development for the treatment of benign prostatic hyperplasia.Finasteride monotherapy maintains stable lower urinary tract symptoms in men with benign prostatic hyperplasia following cessation of alpha blockers.The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model.Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men.A retrospective study of clinical outcomes of α-blocker or finasteride monotherapy followed by combination therapy: determination of the period of combination therapy of α-blocker and finasteride.Prostate-specific antigen changes as a result of chlormadinone acetate administration to patients with benign prostatic hyperplasia: a retrospective multi-institutional study.The effect of testosterone treatment on prostate histology and apoptosis in men with late-onset hypogonadism.Stromal-epithelial measurements of prostate cancer in native Japanese and Japanese-American men.The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia.
P2860
Q24234464-4F8CD08C-5B4F-4B8B-93C3-0E4A4337A615Q24546176-000F67EC-502E-4D91-9EC2-DB9595C9255AQ30408224-5D7B9D33-A637-4C00-BBE8-D05EAD659958Q35685850-358EDB69-5BBB-4EE8-B5B2-5588D93F37ABQ36458457-024D05B2-3B6C-400A-8FD3-0C455EC2E647Q36661343-63DF4FDD-CF8A-4419-85AB-171CC3A79D78Q36847310-2775F1A6-1658-4297-9558-5FDE5FFE483CQ37338238-11113E9D-04B8-48D1-BD9B-1EC64E7BEF0DQ37926474-372F8FCC-104F-4FF9-AC0B-E1881D3F41B8Q38052058-A8FCAFD9-FBC4-49CB-9D1B-EE6DF7478204Q38106624-17CD5B35-53BF-46D8-B51E-79860B297127Q38485721-5E31758F-7151-4B37-AD3A-5E97DA6C66C1Q39020100-79E69A53-1555-45F1-8ADA-7E36F514D507Q41054535-2315348A-16C5-4CFF-8107-E40EDA7921AAQ44059679-E4E07640-23AF-4CDF-9185-B3E880796A09Q48273768-6B0E8612-0C24-4F82-8925-1F98833504C9Q51939919-E677A62F-8B5B-4CA3-B228-517A567128BAQ53160861-D512732C-357E-4374-924C-CAF7C56C2117Q53636217-D5156601-EF78-4DAF-B047-3F3308F0076CQ55019942-7F15CAE0-0032-4D1B-9111-0502158BF563
P2860
Long-term effects of finasteride on prostate tissue composition.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Long-term effects of finasteride on prostate tissue composition.
@en
type
label
Long-term effects of finasteride on prostate tissue composition.
@en
prefLabel
Long-term effects of finasteride on prostate tissue composition.
@en
P2093
P1433
P1476
Long-term effects of finasteride on prostate tissue composition.
@en
P2093
Epstein JI
Gormley GJ
Macairan ML
P304
P356
10.1016/S0090-4295(98)00567-6
P407
P577
1999-03-01T00:00:00Z